BlackRock Inc. - HUMACYTE INC ownership

HUMACYTE INC's ticker is and the CUSIP is 44486Q103. A total of 72 filers reported holding HUMACYTE INC in Q3 2022. The put-call ratio across all filers is 0.96 and the average weighting 0.0%.

Quarter-by-quarter ownership
BlackRock Inc. ownership history of HUMACYTE INC
ValueSharesWeighting
Q3 2023$13,186,422
+7.1%
4,500,486
+4.6%
0.00%
Q2 2023$12,310,885
+4.8%
4,304,505
+13.2%
0.00%
Q1 2023$11,752,011
+38.9%
3,803,240
-5.2%
0.00%
Q4 2022$8,461,947
+17.4%
4,010,402
+81.4%
0.00%
Q3 2022$7,210,000
-6.3%
2,211,355
-7.7%
0.00%
Q2 2022$7,693,000
-30.9%
2,396,378
+51.9%
0.00%
Q1 2022$11,140,000
+9.7%
1,577,919
+12.6%
0.00%
Q4 2021$10,158,0001,401,0730.00%
Other shareholders
HUMACYTE INC shareholders Q3 2022
NameSharesValueWeighting ↓
York Capital Management Global Advisors, LLC 2,291,397$16,177,0004.71%
Endowment Wealth Management, Inc. 96,618$682,0000.72%
JOSH ARNOLD INVESTMENT CONSULTANT, LLC 36,171$255,0000.24%
Prescott General Partners LLC 625,100$4,413,0000.20%
CenterBook Partners LP 45,752$323,0000.12%
Gladstone Institutional Advisory LLC 144,867$1,0230.07%
Exos Asset Management LLC 18,609$131,0000.06%
Sciencast Management LP 26,300$182,0000.04%
Y-Intercept (Hong Kong) Ltd 17,125$121,0000.03%
Kovack Advisors, Inc. 31,500$222,0000.02%
View complete list of HUMACYTE INC shareholders